FIBROTECH THERAPEUTICS PTY LTD has a total of 45 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are ALLELIX NEUROSCIENCE INC, LAFON LABOR and PROD CHIM SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Republic of Korea | 6 | |
#4 | China | 5 | |
#5 | Canada | 3 | |
#6 | Hong Kong | 3 | |
#7 | Japan | 3 | |
#8 | Singapore | 3 | |
#9 | Mexico | 2 | |
#10 | New Zealand | 2 | |
#11 | United States | 2 | |
#12 | Hungary | 1 | |
#13 | India | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Acyclic or carbocyclic compounds | |
#3 | Heterocyclic compounds | |
#4 | Medical preparations | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kelly Darren James | 39 |
#2 | Zammit Steven | 32 |
#3 | Williams Spencer John | 32 |
#4 | Stapleton David | 16 |
#5 | Gilbert Richard Ernest | 13 |
#6 | Krum Henry | 11 |
#7 | Steven Zammit | 6 |
#8 | Darren James Kelly | 4 |
#9 | Spencer John Williams | 4 |
#10 | James Kelly Darren | 2 |
Publication | Filing date | Title |
---|---|---|
CA2815390A1 | Methods of treating eye diseases associated with inflammation and vascular proliferation | |
EP2491030A1 | Fused ring analogues of anti-fibrotic agents | |
WO2010144959A1 | Analogues of anti-fibrotic agents | |
KR20160017139A | Halogenated Analogues of Anti-fibrotic Agents | |
WO2008131481A1 | Treatment of mesangioproliferative diseases | |
NZ574028A | Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis | |
WO2008113095A1 | Compositions and therapies comprising tranilast compounds and angiotensin-converting enzyme (ace) inhibitors and/or angiotensin receptor blockers (arb) |